BC
Buddaiahgari Chandramohan Reddy
About Buddaiahgari Chandramohan Reddy
Data last updated:
Buddaiahgari Chandramohan Reddy is a Director at Sai Nikhil Pharma Private Limited (since 2020), Director at Dn Life Sciences India Private Limited (since 2024) and Designated Partner at Metrix Infra & Projects Llp (since 2025), and holds 7 more current directorships. The companies operate in Pharma, Consumer Services and Engineering. The 2 current companies with reported revenue have a combined latest revenue of ₹62.9 Lakh; the largest is Sai Nikhil Pharma Private Limited at ₹62.4 Lakh (FY 2020). Earlier, Buddaiahgari Chandramohan Reddy was a Director at Vindhya Pharma (India) Private Limited (2019–2021).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sai Nikhil Pharma Private Limited U24232TG2010PTC069972 | Director | 03 Oct 2020 | 2010 | ₹62.4 Lakh (FY 2020) | Active |
| Dn Life Sciences India Private Limited U24297TG2009PTC065781 | Director | 01 Apr 2024 | 2009 | ₹45,658 (FY 2023) | Active |
| Metrix Infra & Projects Llp ACL-9858 | Designated Partner | 17 Feb 2025 | 2025 | Active | |
| Aspure Pharma Solutions Private Limited U37003TS2025PTC192871 | Director | 14 Jan 2025 | 2025 | Active | |
| Metrix Engineers India Private Limited U32909TS2024PTC188824 | Director | 28 Aug 2024 | 2024 | Active | |
| Nextgen E&I Solutions Private Limited U42901TS2024PTC183895 | Director | 29 Mar 2024 | 2024 | Active | |
| Dn Life Sciences Private Limited U21001TS2024PTC181776 | Managing Director | 05 Feb 2024 | 2024 | Active | |
| Designated Partner | 05 Jan 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vindhya Pharma (India) Private Limited U24296TG2006PTC050700 | Director | 17 Oct 2019 | 2006 | ₹6.89 Cr (FY 2025) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Buddaiahgari Chandramohan Reddy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Narasimha Reddy Duthala | 00298613 | Sai Nikhil Pharma Private Limited , Dn Life Sciences India Private Limited | Managing Director |
| Duthala Sahithi | 07898099 | Dn Life Sciences India Private Limited , Dn Life Sciences Private Limited and 3 more | Additional Director |
| Raju Sirisilla | 02803922 | Dn Life Sciences India Private Limited | Director |
| Ganesh Chadalawada | 10532832 | Metrix Infra & Projects Llp , Aspure Pharma Solutions Private Limited and 2 more | Designated Partner |
| Kishan Chand Gutta | 10538796 | Metrix Infra & Projects Llp , Aspure Pharma Solutions Private Limited and 2 more | Designated Partner |
| Srilata Talluri | 10791482 | Aspure Pharma Solutions Private Limited | Director |
| Gangadhara Rao Dasam | 10535747 | Nextgen E&I Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Buddaiahgari Chandramohan Reddy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Buddaiahgari Chandramohan Reddy
Buddaiahgari Chandramohan Reddy currently holds 10 directorships: Sai Nikhil Pharma Private Limited (Director, since 03 Oct 2020, revenue ₹62.4 Lakh (FY 2020)); Dn Life Sciences India Private Limited (Director, since 01 Apr 2024, revenue ₹45,658 (FY 2023)); Metrix Infra & Projects Llp (Designated Partner, since 17 Feb 2025); Aspure Pharma Solutions Private Limited (Director, since 14 Jan 2025); Metrix Engineers India Private Limited (Director, since 28 Aug 2024); and 5 more.
Buddaiahgari Chandramohan Reddy was first appointed on 17 Oct 2019 as Director at Vindhya Pharma (India) Private Limited. The most recent appointment on record is 17 Feb 2025 at Metrix Infra & Projects Llp.
The 2 current companies of Buddaiahgari Chandramohan Reddy that report revenue have a combined latest revenue of ₹62.9 Lakh: Sai Nikhil Pharma Private Limited ₹62.4 Lakh (FY 2020); Dn Life Sciences India Private Limited ₹45,658 (FY 2023).
Buddaiahgari Chandramohan Reddy held 1 earlier board appointment: Vindhya Pharma (India) Private Limited (Director, 17 Oct 2019 to 16 Jun 2021).
The current boards of Buddaiahgari Chandramohan Reddy's companies include Narasimha Reddy Duthala (Sai Nikhil Pharma Private Limited), Duthala Sahithi (Dn Life Sciences India Private Limited), Raju Sirisilla (Dn Life Sciences India Private Limited), Ganesh Chadalawada (Metrix Infra & Projects Llp), Kishan Chand Gutta (Metrix Infra & Projects Llp), Srilata Talluri (Aspure Pharma Solutions Private Limited), among others.